1. Home
  2. TWI vs IPSC Comparison

TWI vs IPSC Comparison

Compare TWI & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Titan International Inc. (DE)

TWI

Titan International Inc. (DE)

HOLD

Current Price

$7.68

Market Cap

494.4M

Sector

Industrials

ML Signal

HOLD

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.35

Market Cap

441.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWI
IPSC
Founded
1890
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
494.4M
441.9M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
TWI
IPSC
Price
$7.68
$2.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$12.00
$4.25
AVG Volume (30 Days)
547.5K
2.1M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.30
EPS
N/A
N/A
Revenue
N/A
$109,164,000.00
Revenue This Year
$3.69
N/A
Revenue Next Year
$4.85
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1556.76
52 Week Low
$6.43
$0.44
52 Week High
$11.70
$2.97

Technical Indicators

Market Signals
Indicator
TWI
IPSC
Relative Strength Index (RSI) 53.55 52.22
Support Level $7.14 $2.14
Resistance Level $8.03 $2.53
Average True Range (ATR) 0.28 0.17
MACD 0.04 -0.01
Stochastic Oscillator 72.83 53.19

Price Performance

Historical Comparison
TWI
IPSC

About TWI Titan International Inc. (DE)

Titan International Inc is a manufacturer of wheels, tires, wheel and tire assemblies, and undercarriage systems and components for off-highway vehicles. It designs and manufactures products for OEMs and aftermarket customers in the agricultural, earthmoving/construction, and consumer markets. The company operates through three segments, namely Agricultural, Earthmoving/Construction, and Consumer. It derives the majority of revenue from the Agricultural segment which manufactures various agricultural equipment, including tractors, combines, plows, planters and irrigation equipment. Geographically, the company generates the maximum revenue from North America, followed by Europe / CIS, Latin America, and Asia and other regions.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

Share on Social Networks: